In this issue:
- Ustekinumab for SLE
- Biomarkers for stratifying response to B-cell-targeted therapies in SLE
- Achilles’ enthesitis associated with worse AS outcomes
- Online yoga for knee OA pain/function
- Anti-TNF, other biologic and JAK inhibitor retention in RA after JAK inhibitor discontinuation
- Disease activity and HLA-B27 both associate with gut microbiome dysbiosis in SpA
- Associations of tramadol with mortality, CV diseases, VTE and hip fractures
- Upadacitinib for active AS refractory to biologics
- Quality of care for people hospitalised with gout in NZ
- Tapering methotrexate from targeted therapy in controlled RA
Please login below to download this issue (PDF)